ClinicalTrials.gg
Sign In

Peripheral Arterial Disease clinical trials

The registry lists 1,377 studies for Peripheral Arterial Disease across more than 10 countries. 275 are recruiting or about to start. 961 of them are mainly about Peripheral Arterial Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Chronic Limb-Threatening Ischemia: 1,695 studies, 328 open.

ClinicalTrials.gov finds 2,355 studies for Peripheral Arterial Disease. How that becomes 1,377 here

This page counts the studies the registry files under Peripheral Arterial Disease, and those it files under no condition that list Peripheral Arterial Diseasethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 2,355Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −314Filed under a narrower condition, counted on its own pageChronic Limb-Threatening Ischemia 217 · Intermittent Claudication 97
  3. −7List Peripheral Arterial Disease as a condition, but the registry did not file them under itMost often written as “PAD - Peripheral Arterial Disease” (4), “Symptomatic Peripheral Artery Disease (Symptomatic PAD)” (1), and “Occlusive Peripheral Arterial Disease” (1). The registry filed them under other conditions only, most often Coronary Artery Disease (1) and Peripheral Vascular Diseases (1).
  4. −657Match it another way61 name it in the title, 1 in a keyword, and 595 by a synonym or other text the search reads.
  5. 1,377The count on this page15 of them list Peripheral Arterial Disease in their own words; the registry filed them under no condition.

Get an email when these change. Save the Peripheral Arterial Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
718
Recruiting
192
Status unknown
188
Terminated
84
Not yet recruiting
72
Active, not recruiting
58

Phase

Phase 2
123
Phase 3
88
Phase 4
86
Phase 1
79
Early Phase 1
16

Where

United States
479
Germany
173
France
120
Belgium
85
United Kingdom
82
China
80

Who runs them

Northwestern University (26) · University Hospital, Angers (24) · Medtronic Endovascular (21) · VA Office of Research and Development (16) · C. R. Bard (15) · Spectranetics Corporation (15) · Cook Group Incorporated (14) · University of Nebraska (12)

What is being tested here

Drugs under test in Peripheral Arterial Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Aspirin4313
Rivaroxaban3212
Clopidogrel3310
Colchicine324
Metformin225
Ticagrelor1410
Carnosine104
Nicotinamide-beta-riboside123
Temsirolimus112
Pegulicianine101

Drug classes tested here P2Y12 inhibitors 3 open · Factor Xa inhibitors 3 open · Antimitotic agents 3 open · mTOR inhibitors 2 open · GLP-1 receptor agonists 1 open

Coming up

16phase 3 studies under way
89studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 192 Peripheral Arterial Disease studies recruiting now, 138 (72%) set no upper age limit and 9 (5%) stop at 75 or younger. 13 (7%) take children under 18. 0 (0%) are for women only and 3 (2%) for men only; 19 (10%) take healthy volunteers.

Recruiting studies that take each age, of 192
AgeWomenMen
1013 (7%)13 (7%)
18142 (74%)143 (74%)
30158 (82%)160 (83%)
40172 (90%)174 (91%)
50186 (97%)188 (98%)
65188 (98%)191 (99%)
75185 (96%)188 (98%)
85164 (85%)166 (86%)

Across all 1,377 studies, recruiting or not: 6% stop at 75 or younger and 2% at 65; 5% take children; <1% are for women only and 1% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Peripheral Arterial Disease studies take

Of 28 phase 4 interventional studies under Peripheral Arterial Disease, half reached primary completion within 35 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 127 mo9–41 · 26 studies——
Phase 248 mo22–61 · 27 studies——
Phase 351 mo37–58 · 26 studies——
Phase 435 mo18–56 · 28 studies——
Interventional, no phase31 mo17–55 · 385 studies28 mo14–45 · 125 studies33 mo17–64 · 260 studies
Observational36 mo22–73 · 196 studies31 mo17–39 · 58 studies40 mo24–116 · 138 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Results posted1

Stopped3

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,377. Browse all 1,377 → or search them.